Fig. 3From: Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysisRisk factors analysis of thrombotic events for COVID-19 patientsThrombotic risk of D-dimer (a), LDH (b), WBC (c), lymphocytes (d), age (e), platelets count (f), gender (g), BMI (h), hypertension (i), coronary artery disease (j), current-smoking (k), malignancy (l), CRP (m), hemoglobin (n), fibrinogen (o), and diabetes (p) for COVID-19 patients. q, The risk of motality for COVID-19 patients with thrombotic events. Note: Heterogeneity is defined according to the I2 index calculated. Random or fixed effect models were used base on the heterogeneityBack to article page